Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.

LeBlanc VG, Firme M, Song J, Chan SY, Lee MH, Yip S, Chittaranjan S, Marra MA.

J Pathol. 2017 Jun;242(2):206-220. doi: 10.1002/path.4894. Epub 2017 Apr 26.

2.

A Diatom Ferritin Optimized for Iron Oxidation but Not Iron Storage.

Pfaffen S, Bradley JM, Abdulqadir R, Firme MR, Moore GR, Le Brun NE, Murphy ME.

J Biol Chem. 2015 Nov 20;290(47):28416-27. doi: 10.1074/jbc.M115.669713. Epub 2015 Sep 22.

3.

Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity.

Chittaranjan S, Chan S, Yang C, Yang KC, Chen V, Moradian A, Firme M, Song J, Go NE, Blough MD, Chan JA, Cairncross JG, Gorski SM, Morin GB, Yip S, Marra MA.

Oncotarget. 2014 Sep 15;5(17):7960-79.

4.

The molecular landscape of pediatric brain tumors in the next-generation sequencing era.

Firme MR, Marra MA.

Curr Neurol Neurosci Rep. 2014 Sep;14(9):474. doi: 10.1007/s11910-014-0474-4. Review.

PMID:
25037717
5.

Extensive cotransformation of natural variation into chromosomes of naturally competent Haemophilus influenzae.

Mell JC, Lee JY, Firme M, Sinha S, Redfield RJ.

G3 (Bethesda). 2014 Apr 16;4(4):717-31. doi: 10.1534/g3.113.009597.

6.

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.

Yip S, Butterfield YS, Morozova O, Chittaranjan S, Blough MD, An J, Birol I, Chesnelong C, Chiu R, Chuah E, Corbett R, Docking R, Firme M, Hirst M, Jackman S, Karsan A, Li H, Louis DN, Maslova A, Moore R, Moradian A, Mungall KL, Perizzolo M, Qian J, Roldan G, Smith EE, Tamura-Wells J, Thiessen N, Varhol R, Weiss S, Wu W, Young S, Zhao Y, Mungall AJ, Jones SJ, Morin GB, Chan JA, Cairncross JG, Marra MA.

J Pathol. 2012 Jan;226(1):7-16. doi: 10.1002/path.2995. Epub 2011 Nov 10.

7.

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA.

Nature. 2011 Jul 27;476(7360):298-303. doi: 10.1038/nature10351.

Supplemental Content

Support Center